Filtered By:
Vaccination: Pneomococcal Vaccine

This page shows you your search results in order of date. This is page number 5.

Order by Relevance | Date

Total 244 results found since Jan 2013.

Hypersentivity reactions to COVID-19 vaccines: a case of Eosinophilic pneumonia following Sinovac/CoronaVac vaccination
Eur Ann Allergy Clin Immunol. 2022 Feb 11. doi: 10.23822/EurAnnACI.1764-1489.247. Online ahead of print.ABSTRACTHypersensitivity reactions has been reported with COVID-19 vaccines. Acute eosinophilic pneumonia has not been reported yet after Sinovac/CoronaVac vaccine. A 73-year-old woman presented with maculopapular rash, cough and dyspnea following Sinovac/CoronaVac injection. The complete blood count (CBC) indicated eosinophilia and further evaluation of the eosinophilia with CT and bronchoscopy confirmed a diagnosis of acute eosinophilic pneumonia. After methylprednisolone therapy, her rash resolved with marked improvem...
Source: European Annals of Allergy and Clinical Immunology - February 14, 2022 Category: Allergy & Immunology Authors: A B Ozturk B Çağlayan M Kapmaz I Çalık S Tekin S İliaz P F ırat Source Type: research

Descriptive Study of IgG Protection for PCV13 Serotypes in Immunodeficient Patients on IVIG
Intravenous immunoglobulin (IVIG) therapy provides IgG antibodies from a donor pool to immunodeficient patients. Since PCV13 vaccine was introduced in 2010, adult donors may not have received the vaccine, thus not having PCV13 specific antibodies to donate. This descriptive analysis will highlight how pneumococcal vaccination affects Streptococcus pneumoniae protection, hospitalization rates, and associated comorbidities in immunodeficient individuals.
Source: Journal of Allergy and Clinical Immunology - February 1, 2022 Category: Allergy & Immunology Authors: Ethan Kallenberger, Andrea D, Lynn Chollet-Hinton, Marissa Love Source Type: research

Pneumococcal Vaccinations In Young Adults With HIV
CDC guidelines recommend pneumococcal conjugate vaccine (PCV) followed by polysaccharide vaccine (PPSV23) for adult HIV+ patients. This assumes immune compromise. Most young adults with HIV have received PCV as infants.
Source: Journal of Allergy and Clinical Immunology - February 1, 2022 Category: Allergy & Immunology Authors: Jahanzeb Javed, Elizabeth Secord, Eric McGrath Source Type: research

Anti- < b > < i > Ascaris < /i > < /b > IgE as a Risk Factor for Asthma Symptoms among 5-Year-Old Children in Rural Bangladesh with Even Decreased < b > < i > Ascaris < /i > < /b > Infection Prevalence
Conclusions: The anti-Ascaris IgE levels in wheezing and never-wheezing children in the current study significantly decreased concurrently withAscaris infection prevalence compared with their corresponding values in 2001. The contribution of anti-Ascaris IgE to wheezing also dropped from 26% in 2001 to 11% in the current study. Despite significant decreases in the levels and the seroprevalence and its contribution to wheezing, anti-Ascaris IgE remained significantly associated with increased risk of wheezing. Anti-Ascaris IgE significantly increased the risk of wheezing in a general population with a mild to moderateAscari...
Source: International Archives of Allergy and Immunology - January 31, 2022 Category: Allergy & Immunology Source Type: research

Health ‐care utilization for sinusitis after pneumococcal vaccination in patients with low antibody titers
ConclusionMost patients with CRS and RARS have nonprotective antibody titers. PPSV23 administration significantly decreases health-care utilization.
Source: International Forum of Allergy and Rhinology - January 10, 2022 Category: Allergy & Immunology Authors: Anna K. Bareiss, Nrusheel Kattar, Rick Tivis, Graham Unis, Triet Do, Lawrence Montelibano, Eboni G. Price ‐Haywood, Edward McCoul Tags: ORIGINAL ARTICLE Source Type: research

Healthcare utilization for sinusitis after pneumococcal vaccination in patients with low antibody titers
CONCLUSIONSMost patients with CRS and RARS have non-protective antibody titers. PPSV23 administration significantly decreases healthcare utilization.This article is protected by copyright. All rights reserved
Source: International Forum of Allergy and Rhinology - December 28, 2021 Category: Allergy & Immunology Authors: Anna K. Bareiss, Nrusheel Kattar, Rick Tivis, Graham Unis, Triet Do, Lawrence Montelibano, Eboni G. Price ‐Haywood, Edward McCoul Tags: ORIGINAL ARTICLE Source Type: research

Psychological Impacts of COVID-19 on people with Asthma, Allergic Rhinitis and Food Allergy
Coronavirus disease of 2019 (COVID-19) is a respiratory illness characterized by fever, cough, dyspnea, fatigue, and lymphopenia. Severe COVID-19 complications can manifest as viral pneumonia and may lead to severe acute respiratory syndrome and, in some cases, death [1, 2]. As of December 2021, SARS-CoV-2 has caused more than 263,300,000 infections, and over 5,221,000 deaths. Since December 2020, over 8,033,000,000 vaccine doses have been administered [3]. A global systematic review conducted during the COVID-19 pandemic of the general public's psychological outcomes found relatively high rates of anxiety (6.33% to 50.9%)...
Source: Annals of Allergy, Asthma and Immunology - December 28, 2021 Category: Allergy & Immunology Authors: Alyssa G. Burrows, Anne K. Ellis Tags: Review Source Type: research

Delayed hypersensitivity to the Comirnaty COVID-19 vaccine presenting with pneumonitis and rash
Ann Allergy Asthma Immunol. 2021 Nov 20:S1081-1206(21)01274-6. doi: 10.1016/j.anai.2021.11.014. Online ahead of print.NO ABSTRACTPMID:34813953 | PMC:PMC8605811 | DOI:10.1016/j.anai.2021.11.014
Source: Annals of Allergy, Asthma and Immunology - November 23, 2021 Category: Allergy & Immunology Authors: Dr Alex Stoyanov Dr Graeme Thompson Dr Monique Lee Professor Connie Katelaris Source Type: research